Insiders Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Real-time Estimate Cboe BZX Other stock markets 10:50:32 14/05/2024 pm IST			5-day change	1st Jan Change
0.735 ^USD	+2.08%		+1.26%	-18.83%

07/05	Gossamer Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
06/05	Chiesi Farmaceutici S.P.A Gossamer Bio, Inc Announces Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pulmonary Arterial Hypertension and Other Respiratory Indications	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gossamer Bio Announces Board of Directors Appointments	12/03	CI
Gossamer Bio Inc. Appoints Bob Smith as Chief Commercial Officer	05/12	CI
Gossamer Bio, Inc. Appoints John Quisel to Its Board of Directors	29/11	CI
Gossamer Bio, Inc. Announces Resignation of Kristina Burow from the Board of Directors	08/23/08	CI
Insider Buy: Gossamer Bio	16/22/16	MT
Insider Sell: Gossamer Bio	25/22/25	MT
Gossamer Bio : Names Bryan Giraudo as Operations Chief	21/21/21	MT
Gossamer Bio Appoints Bryan Giraudo as Chief Operating Officer	21/21/21	CI
Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer	22/21/22	CI
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors	15/21/15	CI
Gossamer Bio, Inc. Announces Chief Scientific Officer Changes, Effective April 30, 2021	20/21/20	CI
Gossamer Bio, Inc. Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs	16/21/16	CI
Gossamer Bio, Inc. Announces Executive Changes	18/20/18	CI
Gossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive Officer	16/20/16	CI
Gossamer Bio, Inc. Announces Departure of Otello Stampacchia from its Board of Directors	13/19/13	CI
Gossamer Bio, Inc. Announces the Cessation of Faheem Hasnain as Executive Chairman and Transition to the Role of Non-Executive Chairman of the Board, Effective June 3, 2019	30/19/30	CI
Gossamer Bio, Inc. Announces Executive Changes	19/18/19	CI
Gossamer Bio, Inc. Announces Appointment of Jakob Dupont as Chief Medical Officer	17/18/17	CI
Gossamer Bio, Inc. Bio Announces Appointment of Luisa Salter-Cid as Chief Scientific Officer	05/18/05	CI
Gossamer Bio, Inc. Announces Executive Changes	23/18/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Insiders

Filters